Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue
Marie‐Madeleine Dolmans(Cliniques Universitaires Saint-Luc), T. Grève(Copenhagen University Hospital), Jacques Donnez(UCLouvain), Claus Yding Andersen(Herlev Hospital), Valérie A. Luyckx(Brigham and Women's Hospital)
Cited by 335
Related Papers
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue
|The Lancet|2004|1.6k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
The global burden of kidney disease and the sustainable development goals
|Bulletin of the World Health Organization|2018|917
Fertility Preservation in Women
|New England Journal of Medicine|2017|839
Uterine fibroid management: from the present to the future
|Human Reproduction Update|2016|750